The effect of CD3-specific monoclonal antibody on treating experimental autoimmune myasthenia gravis.


CD3-specific monoclonal antibody was the first one used for clinical practice in field of transplantation. Recently, renewed interests have elicited in its capacity to prevent autoimmune diabetes by inducing immune tolerance. In this study, we tested whether this antibody can also be used to treat another kind of autoimmune disease myasthenia gravis (MG… (More)


4 Figures and Tables